Internet Stroke Center Home Stroke Education for Clinicians & Students
 

Patients & Families   Health Professionals   Clinical Trials   About   Home 


Search the ISC 
Search the Web
 Stroke Education
Section Home
Glossary of
Neurological Terms

 Stroke Management
Thrombolytic Case Management Series
CT Learning Tool
Evaluation & Diagnosis
Stroke Care for EMT's & Paramedics
Management of Oral Anticoagulant Therapy
 Brain Anatomy
Anatomy of the Brain
Blood Vessels of the Brain
Pathogenesis & Pathophysiology
 Brain Imaging
Neurology Image Library
CT & MRI Criteria for Infarction & Hemorrhage
Guide to Imaging Techniques
MRI Compared to CT
 Stroke Facts
Epidemiology of Stroke
Stroke Risk Factors
Types of Stroke


Part One: Warfarin Dosing Guidelines

Conversion from Heparin to Warfarin

  • May begin concomitantly with heparin therapy

  • Heparin should be continued for a minimum of four days

  • Time to peak antithrombotic effect of warfarin is delayed 96 hours (despite INR)

  • When INR reaches desired therapeutic range, discontinue heparin (after a minimum of four days)

Notes:

When short-term heparin followed by long-term warfarin are used, both anticoagulants can be started simultaneously. Heparin should be continued for a minimum of four days because the peak antithrombotic effect of warfarin is delayed for about 96 hours, independently of the INR, until Factor II (prothrombin is reduced). Heparin can be discontinued after a minimum of four days when the INR reaches the therapeutic range.

  

Back

Contents

Next

 

About this presentation:

The content of these pages is from a presentation called  "Management of Oral Anticoagulant Therapy: Principles & Practice," prepared by the American Heart Association's Post-Graduate Education Committee of the Council on Clinical Cardiology.  Supported by an educational grant from DuPont Pharmaceuticals.

Authors: Jack Ansell, M.D., Jack Hirsch, M.D., Nanette K. Wenger, M.D.

Data current as of October 1999.

Endorsed by the Anticoagulation Forum and the American Heart Association Council on Atherosclerosis, Thrombosis, and Vascular Biology.

The entire PowerPoint presentation is available from the American Heart Association.

 

 

This site is a non-profit, educational service of Washington University School of MedicineInternet Stroke Center at Washington University:
TOP | HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997 - 2007 Internet Stroke Center. All rights reserved.

The information in this web site is not a substitute for medical advice or treatment.
Consultation with your doctor or health care professional is recommended.